Article

2011 ACC VIDEO: Cost Analysis of Atrial Fibrillation and Congestive Heart Failure

Conference|American College of Cardiology

Dr. Poulin discusses his poster which is a cost analysis of patients in an atrial fibrillation and congestive heart failure trial.

Dr. Poulin discusses his poster which is a cost analysis of 300 patients from Quebec, Canada in an atrial fibrillation and congestive heart failure trial.

Related Videos
New ‘Level Up’ Data on Upadacitinib (Rinvoq) for Atopic Dermatitis, with Christopher Bunick, MD, PhD
Julie Refardt, MD, PhD: Current Hyponatremia Clinical Interventions Sufficient
Richard Pratley, MD | Credit: Advent Health Diabetes Institute
Christopher Bunick, MD, PhD: Facts About Systemic Therapies’ Safety, Mechanism of Action
Carla Nester, MD | Credit: HCPLive
Shawn Kwatra, MD: Making the Connection Between Prurigo Nodularis, Atopic Dermatitis, and Itch
Will Herrington, MBBS, MD, MA: Empagliflozin Follow-up Data Informs Clinical Care for CKD
Jennifer Lai Yee, MD, PhD, MPH: Honing in on Sparsentan’s Benefit in Genetic FSGS
Highlighting Recent Therapies for Dermatologists, with James Del Rosso, DO
Ladan Zand, MD: Obinutuzumab Promising Option for Refractory, Primary FSGS
Related Content
Jonathan Barratt, PhD | Credit: IgA Nephropathy Foundation
October 27th 2024

ORIGIN OLE Data Solidify Atacicept Disease-Modifying Potential for IgA Nephropathy

Patrick Campbell
Kidney Compass: Atacicept for IgAN with Jonathan Barratt, PhD, at Kidney Week 2024
October 27th 2024

Kidney Compass: Atacicept for IgAN with Jonathan Barratt, PhD, at Kidney Week 2024

Brendon Neuen, MBBS, PhD Shikha Wadhwani, MD, MS
Depagliflozin Lowers Risk of Decline in Late-Stage Kidney Disease
October 26th 2024

Depagliflozin Lowers Risk of Decline in Late-Stage Kidney Disease

Victoria Johnson
Taher Modarressi, MD | Credit: X.com
October 3rd 2024

Don't Miss a Beat: Putting Evidence-Based Cardiometabolic Therapies into Practice, with Taher Modarressi, MD

Muthiah Vaduganathan, MD, MPH Stephen Greene, MD
Carla Nester, MD | Credit: University of Iowa
October 26th 2024

VALIANT: Pegcetacoplan Offers Benefit for UPCR, eGFR, C3 Staining in C3G, IC-MPGN

Patrick Campbell
Despite Guidelines, Systemic Corticosteroids Remain Widely Prescribed for Atopic Dermatitis
October 26th 2024

Despite Guidelines, Systemic Corticosteroids Remain Widely Prescribed for Atopic Dermatitis

Tim Smith
© 2024 MJH Life Sciences

All rights reserved.